Riggs Josh 4
4 · Oncocyte Corp · Filed Apr 15, 2024
Insider Transaction Report
Form 4
Riggs Josh
CEO and President
Transactions
- Purchase
Common Stock, no par value
2024-04-11$2.95/sh+3,390$10,001→ 3,505 total
Footnotes (1)
- [F1]Reflects shares of the Issuer's common stock, no par value, purchased by the Reporting Person from the Issuer in a private offering.